So it was the government shutdown and some insane comments from OpenAI about a government backstop because of gigantic ...
Pfizer Inc. (NYSE:PFE) is one of the latest stocks on Jim Cramer’s radar. Cramer noted that the company could not perform as ...
We recently published 10 Stocks Jim Cramer Discussed Including His Palantir Deep Dive. Pfizer Inc. (NYSE:PFE) is one of the ...
Pfizer Inc. (NYSE:PFE) is one of the stocks highlighted as Jim Cramer responded to questions from Harvard Business School ...
Jim Cramer says Sempra (SRE) is a buy, supported by Wells Fargo's Overweight rating. Pfizer (PFE) and Dow (DOW) discussed.
Miguel Rojas Shares What Shohei Ohtani Told Him After His Massive Home Run in Game 7 Mexican President Claudia Sheinbaum Is ...
TLDR Novo Nordisk launched an unsolicited $9 billion offer for Metsera, trumping Pfizer’s existing $7.3 billion acquisition ...
Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the stocks Jim Cramer was asked about. Mentioning that they are a long-term ...
Lilly will also gain certain rights to MeiraGTx’s proprietary riboswitch technology for use in gene editing in the eye. Under ...
A judge denied Pfizer's ( PFE) request to temporarily block Novo Nordisk's ( NVO) $10 billion bid for Metsera. Metsera rose 2 ...
Analysts expect the health care company to report quarterly earnings at 64 cents per share, down from $1.06 per share in the ...
Pfizer is one of the world's largest pharmaceutical companies. It has a few material patent expirations on the horizon. It's doing what it has to do to deal with that headwind and others. Pfizer is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results